Cynthia Arbeeny

2.2k total citations
37 papers, 1.5k citations indexed

About

Cynthia Arbeeny is a scholar working on Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Cynthia Arbeeny has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Physiology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Cynthia Arbeeny's work include Cancer, Lipids, and Metabolism (6 papers), Diet and metabolism studies (4 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Cynthia Arbeeny is often cited by papers focused on Cancer, Lipids, and Metabolism (6 papers), Diet and metabolism studies (4 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Cynthia Arbeeny collaborates with scholars based in United States, Netherlands and France. Cynthia Arbeeny's co-authors include Dean A. Handley, Vincent A. Rifici, Yves Sabbagh, Shu Chien, Wenping Song, Susan C. Schiavi, Joseph Boulanger, Stephen O’Brien, Howard A. Eder and H. Eder and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Cynthia Arbeeny

36 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cynthia Arbeeny United States 21 547 367 331 280 274 37 1.5k
Haruhisa Otani Japan 18 460 0.8× 453 1.2× 302 0.9× 158 0.6× 155 0.6× 46 1.5k
Shinobu Miyazaki‐Anzai United States 19 442 0.8× 289 0.8× 277 0.8× 134 0.5× 133 0.5× 30 1.3k
Theodore C. Simon United States 20 821 1.5× 285 0.8× 187 0.6× 152 0.5× 95 0.3× 28 1.5k
T K Gray United States 26 595 1.1× 141 0.4× 141 0.4× 179 0.6× 414 1.5× 53 2.0k
Suresh T. Mathews United States 18 777 1.4× 338 0.9× 179 0.5× 498 1.8× 275 1.0× 34 1.7k
Eileen Sutherland United States 16 292 0.5× 256 0.7× 224 0.7× 59 0.2× 119 0.4× 20 1.0k
Akihide Nakao Japan 18 345 0.6× 170 0.5× 409 1.2× 321 1.1× 97 0.4× 36 1.4k
Naoki Morito Japan 20 1.1k 2.0× 442 1.2× 166 0.5× 121 0.4× 197 0.7× 51 1.9k
Christoph Sauvant Germany 23 653 1.2× 271 0.7× 261 0.8× 115 0.4× 303 1.1× 36 1.6k
Jakub Gburek Poland 14 476 0.9× 138 0.4× 288 0.9× 169 0.6× 96 0.4× 39 1.4k

Countries citing papers authored by Cynthia Arbeeny

Since Specialization
Citations

This map shows the geographic impact of Cynthia Arbeeny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia Arbeeny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia Arbeeny more than expected).

Fields of papers citing papers by Cynthia Arbeeny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cynthia Arbeeny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia Arbeeny. The network helps show where Cynthia Arbeeny may publish in the future.

Co-authorship network of co-authors of Cynthia Arbeeny

This figure shows the co-authorship network connecting the top 25 collaborators of Cynthia Arbeeny. A scholar is included among the top collaborators of Cynthia Arbeeny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cynthia Arbeeny. Cynthia Arbeeny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castañeda, Tamara R., María L. Méndez, I. R. Davison, et al.. (2020). The Novel Phosphate and Bile Acid Sequestrant Polymer SAR442357 Delays Disease Progression in a Rat Model of Diabetic Nephropathy. Journal of Pharmacology and Experimental Therapeutics. 376(2). 190–203. 13 indexed citations
2.
Arbeeny, Cynthia, Hong Ling, Stefan Wawersik, et al.. (2019). CXA-10, a Nitrated Fatty Acid, Is Renoprotective in Deoxycorticosterone Acetate-Salt Nephropathy. Journal of Pharmacology and Experimental Therapeutics. 369(3). 503–510. 23 indexed citations
3.
Ling, Hong, Lucy Phillips, William Weber, et al.. (2013). Glomerulopathy in the KK.Cg-Ay/J Mouse Reflects the Pathology of Diabetic Nephropathy. Journal of Diabetes Research. 2013. 1–13. 19 indexed citations
4.
Ling, Hong, Donna Hempel, Jingzang Tao, et al.. (2013). Transforming Growth Factor β Neutralization Ameliorates Pre-Existing Hepatic Fibrosis and Reduces Cholangiocarcinoma in Thioacetamide-Treated Rats. PLoS ONE. 8(1). e54499–e54499. 71 indexed citations
5.
Schiavi, Susan C., Wen Tang, Christina Bracken, et al.. (2012). Npt2b Deletion Attenuates Hyperphosphatemia Associated with CKD. Journal of the American Society of Nephrology. 23(10). 1691–1700. 78 indexed citations
6.
Wang, Xiaoxin X., et al.. (2011). Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism. American Journal of Physiology-Renal Physiology. 300(3). F801–F810. 69 indexed citations
7.
Ke, Qingen, et al.. (2011). Doxercalciferol, a Pro-hormone of Vitamin D, Prevents the Development of Cardiac Hypertrophy in Rats. Journal of Cardiac Failure. 17(12). 1051–1058. 22 indexed citations
8.
Yew, Nelson S., Hongmei Zhao, Eun‐Gyoung Hong, et al.. (2010). Increased Hepatic Insulin Action in Diet-Induced Obese Mice Following Inhibition of Glucosylceramide Synthase. PLoS ONE. 5(6). e11239–e11239. 28 indexed citations
9.
Zhang, Yan, Dilip K. Deb, Juan Kong, et al.. (2009). Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT 1 receptor antagonist. American Journal of Physiology-Renal Physiology. 297(3). F791–F801. 84 indexed citations
10.
Eijk, Marco van, Jan Aten, Nora Bijl, et al.. (2009). Reducing Glycosphingolipid Content in Adipose Tissue of Obese Mice Restores Insulin Sensitivity, Adipogenesis and Reduces Inflammation. PLoS ONE. 4(3). e4723–e4723. 94 indexed citations
11.
Eijk, Marco van, Jan Aten, Nora Bijl, et al.. (2009). Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation. Chemistry and Physics of Lipids. 160. S14–S14. 3 indexed citations
12.
Sabbagh, Yves, Stephen O’Brien, Wenping Song, et al.. (2009). Intestinal Npt2b Plays a Major Role in Phosphate Absorption and Homeostasis. Journal of the American Society of Nephrology. 20(11). 2348–2358. 243 indexed citations
13.
Zhao, Hongmei, Malgorzata Przybylska, Jinhua Zhang, et al.. (2009). Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice #. Hepatology. 50(1). 85–93. 77 indexed citations
14.
Arbeeny, Cynthia. (2004). Addressing the Unmet Medical Need for Safe and Effective Weight Loss Therapies. Obesity Research. 12(8). 1191–1196. 37 indexed citations
15.
Meyers, Daniel S., et al.. (1997). β3-Adrenergic Receptor-Mediated Lipolysis and Oxygen Consumption in Brown Adipocytes from Cynomolgus Monkeys. The Journal of Clinical Endocrinology & Metabolism. 82(2). 395–401. 18 indexed citations
16.
Lipworth, Brian J., David J. Clark, P. Koch, & Cynthia Arbeeny. (1997). Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.. Thorax. 52(10). 849–852. 41 indexed citations
17.
Arbeeny, Cynthia, et al.. (1989). Hyperlipoproteinemia in spontaneously diabetic guinea pigs. Metabolism. 38(9). 895–900. 10 indexed citations
18.
Arbeeny, Cynthia, Vincent A. Rifici, Dean A. Handley, & Howard A. Eder. (1987). Determinants of the uptake of very low density lipoprotein remnants by the perfused rat liver. Metabolism. 36(11). 1106–1113. 5 indexed citations
19.
Handley, Dean A., et al.. (1985). Intralysosomal Accumulation of Colloidal Gold-Low Density Lipoprotein Conjugates in Chloroquine-Treated Fibroblasts. Proceedings annual meeting Electron Microscopy Society of America. 43. 546–547. 1 indexed citations
20.
Handley, Dean A., et al.. (1984). Effect of platelet activating factor on endothelial permeability to plasma macromolecules. Immunopharmacology. 8(3-4). 137–142. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haruhisa Otani Breakdown of academic impact, for papers by Shinobu Miyazaki‐Anzai Breakdown of academic impact, for papers by Theodore C. Simon Breakdown of academic impact, for papers by T K Gray Breakdown of academic impact, for papers by Suresh T. Mathews Breakdown of academic impact, for papers by Eileen Sutherland Breakdown of academic impact, for papers by Akihide Nakao Breakdown of academic impact, for papers by Naoki Morito Breakdown of academic impact, for papers by Christoph Sauvant Breakdown of academic impact, for papers by Jakub Gburek
Rankless by CCL
2026